A Comparative Study of Two Protocols of Concurrent Chemotherapy with External Beam Radiotherapy in Treatment of Locally Advanced Cervical Cancer: Cisplatin Versus Cisplatin Plus Capecitabine Combination

[1] Arbyn M(2020)Estimates of incidence and mortality of cervical cancer in 2018: a worldwide analysis Lancet Glob Health 8 e191-e203

[2] Weiderpass E(2006)Social inequalities in cancer with special reference to South Asian countries Asian Pac J Cancer Prev 7 36-40

[3] Bruni L(2011)ACR appropriateness criteria(R) on advanced cervical cancer expert panel on radiation oncology–gynecology Int J Radiat Oncol Biol Phys 81 609-614

[4] de Sanjosé S(2007)Multimodality therapy for locally advanced cervical carcinoma: state of the art and future directions J Clin Oncol 25 2952-2965

[5] Saraiya M(1999)Pelvic radiation with concurrent chemotherapy compared with pelvic and paraaortic radiation for high-risk cervical cancer N Engl J Med 340 1137-1143

[6] Ferlay J(1999)Concurrent cisplatin based radiotherapy and chemotherapy for locally advanced cervical cancer N Eng J Med 340 1144-1153

[7] Bray F(2005)Randomized comparison of weekly cisplatin or protracted venous infusion of fluorouracil in combination with pelvic radiation in advanced cervix cancer. A gynecologic oncology group study J Clin Oncol 23 8289-8295

[8] Kurkure AP(1999)Randomized comparison of fluorouracil plus cisplatin versus hydroxyurea as an adjunct to radiation therapy in stage IIB-IVA carcinoma of the cervix with negative para-aortic lymph nodes. A gynecologic oncology group and southwest oncology group study J Clin Oncol 17 1339-1348

[9] Yeole BB(2001)Survival and recurrence after concomitant chemotherapy and radiotherapy for cancer of the uterine cervix: a systematic review and meta-analysis Lancet 358 781-786

[10] Gaffney DK(2010)Locally advanced cervical cancer: what is the standard of care? Curr Opin Oncol 22 503-512

[1] Arbyn M(2020)Estimates of incidence and mortality of cervical cancer in 2018: a worldwide analysis Lancet Glob Health 8 e191-e203

[2] Weiderpass E(2006)Social inequalities in cancer with special reference to South Asian countries Asian Pac J Cancer Prev 7 36-40

[3] Bruni L(2011)ACR appropriateness criteria(R) on advanced cervical cancer expert panel on radiation oncology–gynecology Int J Radiat Oncol Biol Phys 81 609-614

[4] de Sanjosé S(2007)Multimodality therapy for locally advanced cervical carcinoma: state of the art and future directions J Clin Oncol 25 2952-2965

[5] Saraiya M(1999)Pelvic radiation with concurrent chemotherapy compared with pelvic and paraaortic radiation for high-risk cervical cancer N Engl J Med 340 1137-1143

[6] Ferlay J(1999)Concurrent cisplatin based radiotherapy and chemotherapy for locally advanced cervical cancer N Eng J Med 340 1144-1153

[7] Bray F(2005)Randomized comparison of weekly cisplatin or protracted venous infusion of fluorouracil in combination with pelvic radiation in advanced cervix cancer. A gynecologic oncology group study J Clin Oncol 23 8289-8295

[8] Kurkure AP(1999)Randomized comparison of fluorouracil plus cisplatin versus hydroxyurea as an adjunct to radiation therapy in stage IIB-IVA carcinoma of the cervix with negative para-aortic lymph nodes. A gynecologic oncology group and southwest oncology group study J Clin Oncol 17 1339-1348

[9] Yeole BB(2001)Survival and recurrence after concomitant chemotherapy and radiotherapy for cancer of the uterine cervix: a systematic review and meta-analysis Lancet 358 781-786

[10] Gaffney DK(2010)Locally advanced cervical cancer: what is the standard of care? Curr Opin Oncol 22 503-512